- Feasibility figures true to delivery
- Regulatory dynamics for strategic advantages
- Collaborate with patients and physicians to enhance access to innovative therapies
- New study designs that accelerate development programs
Archives: Agenda
Maximizing the consultative partnership between CRO and pharma/biotech partners
- How early engagement can improve outcomes
- How do we speak the same language, no one size fits all approach
- Simplifying the complex, in a world of overwhelming outsourcing options and models
Patient perspective: My clinical trial journey
- Details of my two hybrid clinical trial participations
- What worked well during the trials
- Areas of improvement observed during/after the trials
- Recommendations for ensuring patient-centric trial design
Patient advocacy groups: Bridging clinical trials and patient communities for meaningful DEI impact
- Understand the need for collaborative partnerships with patient advocacy groups
- Discuss valuable insights these groups provide into the patient journey, clinical trial design, and study participation to reduce barriers faced by diverse patient populations
- Share best practices for leveraging advocacy groups to enhance patient recruitment and retention
- Explore how patient advocacy groups help align the objectives of clinical trials with broader diversity and inclusion goals
Chair’s opening remarks
Registration & Refreshments
Start expecting more from eCOA/ePRO
Patient data is the lifeblood of a clinical trial, but the eCOA/ePRO market has yet to live up to the promise of engaging more patients. Sponsors and CROs should expect more. We need an objective look at where the market is lagging, and concrete steps we can take to improve.
- Describe why a legacy eCOA/ePRO system will not deliver the same results as a system developed with modern, digital technology
- Examine how eCOA/ePRO technologies should promote compliance by giving patients apps that are akin to apps they use in daily life, on their own devices
- Discuss how eCOA/ePRO will not become a strategic component of sponsor and CROs technology portfolios unless vendors embrace continuous innovation
END OF DAY 1 AND NETWORKING DRINKS SPONSORED BY Dr. Vince Clinical Research

What do you mean you need equipment? Demystifying the complexities of the equipment supply chain
- Explore the critical role of equipment in enabling clinical trial success, from ensuring compliance to supporting protocol-specific needs.
- Understand key challenges in the equipment supply chain, including global logistics, maintenance, and vendor management.
- Discover practical solutions, such as centralized planning, global harmonization, and leveraging technology for supply chain optimization.
- Learn from real-world examples illustrating how proactive equipment management saves time, reduces costs, and ensures trial continuity.
Ensuring that vendor oversight is embedded from end-to-end
- Effectively implementing a risk-based approach to vendor oversight
- How to right-size vendor oversight for our high-risk activities being outsourced
- Why is vendor oversight important and what regulations drive this
- Recognizing the importance of cross-functional collaboration to best manage vendor activity